data_1bjc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bjc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 122.235 1.017 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.782 0.801 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 122.095 0.95 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.422 0.63 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.625 0.726 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 122.322 1.058 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.487 0.66 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.07 60.7 2.03 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.35 1.031 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.31 35.88 0.4 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.365 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -154.98 13.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.887 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -68.31 71.95 0.19 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.774 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.47 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.68 45.6 12.78 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.024 0.916 . . . . 0.0 110.129 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -68.77 -34.98 76.47 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.027 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.66 4.49 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.18 163.58 9.05 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.415 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.26 104.69 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.6 t -81.99 -44.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.156 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.88 30.86 14.62 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -156.63 110.55 2.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.107 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -83.6 51.63 2.06 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.498 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.82 150.92 17.03 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.3 m -88.06 32.77 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.301 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -58.61 -36.13 73.56 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.061 -1.923 . . . . 0.0 110.246 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.59 142.84 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.009 0.818 . . . . 0.0 110.07 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.51 32.6 1.98 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.638 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -152.02 62.91 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.713 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -164.08 33.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.561 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.9 t60 51.16 17.43 0.47 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.588 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 52.72 32.06 11.44 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.331 0.586 . . . . 0.0 111.684 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.2 m 55.82 17.06 2.3 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.693 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.31 88.71 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.62 -175.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.279 0.635 . . . . 0.0 111.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -174.0 113.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.26 -34.2 53.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.272 -1.785 . . . . 0.0 108.134 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 67.86 -18.56 0.15 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.882 -1.508 . . . . 0.0 114.452 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.78 93.54 2.22 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 10.87 3.0 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.11 79.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -45.26 -34.41 2.86 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.365 0.686 . . . . 0.0 112.761 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -137.82 -26.42 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.034 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 116.905 -1.522 . . . . 0.0 109.097 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.97 146.64 25.13 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.325 1.059 . . . . 0.0 112.031 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.83 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.308 -2.223 . . . . 0.0 106.974 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -81.79 34.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.619 -1.628 . . . . 0.0 112.449 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -76.45 76.19 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t60 51.26 11.97 0.12 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.72 29.26 18.02 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.84 0.829 . . . . 0.0 109.57 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.3 p -70.88 -31.77 68.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.87 89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -70.71 -165.13 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 124.045 0.497 . . . . 0.0 111.139 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -172.47 115.58 0.32 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.42 -54.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.523 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -178.15 -51.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.42 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -155.55 114.93 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.815 1.322 . . . . 0.0 108.971 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -123.15 15.73 9.87 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -37.36 3.53 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m 56.54 14.15 1.59 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 124.36 0.683 . . . . 0.0 112.481 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.26 -23.55 65.71 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.268 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 pttm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.529 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.22 105.09 17.58 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.4 120.24 10.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -80.43 54.71 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.723 1.264 . . . . 0.0 110.364 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -101.34 49.56 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.4 -1.727 . . . . 0.0 108.539 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 60.89 17.96 8.3 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.695 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.0 t0 59.4 56.21 3.85 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 m -81.3 57.17 3.12 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.256 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.29 -2.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.819 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -167.27 -179.89 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.168 0.509 . . . . 0.0 110.142 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -171.33 100.17 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.51 -29.27 34.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.745 -1.571 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.1 26.78 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.753 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.2 p80 36.89 42.54 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 123.141 1.448 . . . . 0.0 112.998 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 13.45 0.14 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.683 -2.053 . . . . 0.0 115.502 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.1 -124.75 14.42 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.412 ' HG ' ' H ' ' A' ' 27' ' ' ASN . 15.9 p -167.18 -42.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.141 0.553 . . . . 0.0 109.818 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' H ' ' HG ' ' A' ' 26' ' ' SER . 4.6 t30 -87.17 -38.34 16.49 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.166 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.247 0 O-C-N 125.132 1.52 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.69 133.54 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.366 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -126.52 17.75 7.54 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.128 0.893 . . . . 0.0 111.633 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' H ' ' NH1' ' A' ' 5' ' ' ARG . 2.1 p90 -107.02 62.14 0.62 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.141 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' NH1' ' H ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -150.52 45.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.027 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m80 53.65 59.86 4.05 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.113 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.27 71.19 5.78 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.6 p -62.36 -38.03 87.97 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.66 -101.49 0.22 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.94 160.81 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.786 0.803 . . . . 0.0 111.643 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.82 122.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.63 -52.82 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.041 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.26 -2.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.889 1.368 . . . . 0.0 110.899 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.4 t60 43.04 66.27 0.81 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.159 0.912 . . . . 0.0 111.965 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 8.33 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.84 -1.527 . . . . 0.0 112.369 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 146.93 31.6 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 p -163.79 -39.7 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.9 43.79 1.14 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.609 -1.662 . . . . 0.0 110.124 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.37 70.31 0.85 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.86 80.09 2.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.12 0.962 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -148.66 29.09 0.85 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.637 -1.62 . . . . 0.0 107.617 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.54 35.46 0.3 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 125.114 1.509 . . . . 0.0 111.816 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 t60 73.73 51.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 111.682 -2.508 . . . . 0.0 111.335 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t0 52.4 52.36 14.35 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.813 -1.539 . . . . 0.0 109.699 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 t 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.57 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.21 -37.88 3.1 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.88 165.24 23.0 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -170.37 104.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.75 -55.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -179.33 -59.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.256 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -170.47 -111.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.352 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 48.8 48.27 20.38 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.25 -170.12 18.44 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m 43.54 36.34 1.16 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.511 0.672 . . . . 0.0 112.759 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.43 -36.7 66.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.25 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' H ' ' HZ1' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 116.23 -1.843 . . . . 0.0 109.843 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.64 -166.46 0.77 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.865 0.84 . . . . 0.0 110.004 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.58 101.08 10.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -86.67 51.61 2.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.079 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -131.67 50.96 2.18 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.95 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 50.5 40.09 22.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.3 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.84 80.34 6.25 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 t -65.33 -29.25 69.97 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.587 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.55 -12.78 9.46 Favored Glycine 0 N--CA 1.496 2.666 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.119 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -165.4 163.59 19.76 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.869 0.842 . . . . 0.0 112.057 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -172.17 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.95 -33.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 113.28 -1.782 . . . . 0.0 108.947 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 4.79 1.18 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -167.96 143.49 3.81 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.987 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.02 26.76 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.577 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.51 -163.18 11.34 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 p -155.01 70.81 0.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.67 -2.49 1.21 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.466 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 115.707 -2.092 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.04 72.53 0.49 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.348 1.03 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.4 45.58 1.2 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.009 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.75 18.33 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.356 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -81.86 78.98 8.51 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.397 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.7 m80 65.96 76.07 0.32 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.0 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.81 30.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 m 63.69 8.76 3.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.938 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.63 -101.47 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -162.35 161.44 27.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.516 0.674 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -163.75 106.85 0.97 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.13 -57.02 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.163 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.547 ' HD1' ' H ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -174.24 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.108 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.547 ' H ' ' HD1' ' A' ' 13' ' ' HIS . 0.3 OUTLIER 46.94 57.91 5.24 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.981 1.372 . . . . 0.0 111.145 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -81.91 27.24 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.277 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.52 77.92 1.03 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 m -68.23 -18.3 64.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.946 -0.627 . . . . 0.0 112.098 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.91 2.94 2.37 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 124.16 0.913 . . . . 0.0 112.206 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 129.55 8.59 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.576 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.94 20.9 1.72 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.03 0.831 . . . . 0.0 112.028 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 53.56 58.59 5.03 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -81.52 67.83 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.29 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -165.15 -64.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.398 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t0 53.48 55.49 8.57 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.585 1.178 . . . . 0.0 110.051 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -57.59 -32.42 67.16 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.782 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.21 17.19 56.71 Favored Glycine 0 N--CA 1.497 2.763 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.035 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 61.94 157.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.207 1.003 . . . . 0.0 113.177 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -176.84 127.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.04 -34.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 124.62 1.2 . . . . 0.0 110.844 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 77.95 -53.75 0.51 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.654 1.846 . . . . 0.0 110.288 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -176.86 161.57 2.01 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 123.893 0.746 . . . . 0.0 109.824 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 51.57 0.08 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.154 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.51 40.95 45.98 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -53.73 -35.64 61.42 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.241 -0.979 . . . . 0.0 112.541 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.63 -23.32 11.52 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.707 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.26 178.49 8.36 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.878 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.91 96.09 8.68 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.47 -1.695 . . . . 0.0 106.555 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.7 51.02 2.02 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.142 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 45.22 24.18 0.13 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.949 -1.478 . . . . 0.0 114.478 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -173.72 9.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.398 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.7 21.78 0.64 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p 44.6 20.03 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.47 -65.3 3.24 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.05 165.8 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.403 0.62 . . . . 0.0 112.087 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.25 127.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.11 -64.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.511 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 54.64 6.35 0.11 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.778 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -78.04 -83.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 50.3 22.19 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.57 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.9 m -59.87 -33.07 71.33 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 58.3 6.34 0.53 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 116.315 -1.803 . . . . 0.0 109.16 179.749 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.935 0.398 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 4' ' ' PHE . . . -133.84 121.87 22.4 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.72 23.0 0.34 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.721 0.772 . . . . 0.0 112.103 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 2' ' ' ALA . 34.9 p90 -143.21 20.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.9 ttm-85 -80.56 78.18 7.31 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.738 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 t60 59.0 27.5 16.45 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.07 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 57.99 67.23 0.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.934 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -51.35 -32.94 27.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.934 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.66 31.18 52.93 Favored Glycine 0 N--CA 1.497 2.761 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.809 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -162.83 165.3 25.5 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.45 0.643 . . . . 0.0 112.001 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -164.63 103.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -77.41 -30.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.235 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.2 m80 78.34 -51.16 0.48 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.444 1.715 . . . . 0.0 109.4 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -82.92 -153.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.825 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 53.07 31.64 11.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.64 22.15 2.55 Favored Glycine 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t 55.98 22.46 5.82 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -138.85 -32.34 0.69 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.24 0.337 . . . . 0.0 111.529 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -179.782 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.99 57.18 0.66 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.982 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.69 28.65 1.11 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.022 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 22.38 13.13 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.974 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 6.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.024 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -80.89 -54.63 5.42 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.791 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.6 23.78 0.4 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.621 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 -44.95 7.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.4 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.58 47.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.279 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 p90 39.08 -149.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.12 126.06 3.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.9 t -89.74 -30.58 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.754 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 78.51 -33.6 0.16 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.786 1.304 . . . . 0.0 111.333 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.417 ' C ' ' H ' ' A' ' 16' ' ' PHE . 42.1 m80 -77.29 79.31 3.81 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.904 0.859 . . . . 0.0 109.169 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.0 33.85 0.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.308 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 14' ' ' HIS . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.17 111.85 0.47 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 t -157.13 -33.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.963 0.449 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.88 41.36 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.699 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.51 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.754 0.311 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 52.84 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.513 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.38 34.76 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.368 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' C ' ' H ' ' A' ' 6' ' ' HIS . 24.9 m-85 54.53 24.32 5.26 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.305 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.67 9.83 1.3 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.911 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 4' ' ' PHE . 58.6 m-70 -81.4 -20.27 40.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.529 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.2 t70 58.89 29.71 19.21 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.223 0.952 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.2 m -48.02 -21.18 0.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.787 -1.551 . . . . 0.0 114.073 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.06 -27.32 57.12 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 123.997 0.81 . . . . 0.0 112.425 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.02 -179.77 2.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.711 0.301 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -174.43 112.74 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.3 t -80.17 -1.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.279 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 69.39 -2.29 1.93 Allowed 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.604 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.2 p80 26.08 69.71 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.621 1.201 . . . . 0.0 112.932 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -135.34 29.97 3.28 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.494 -2.139 . . . . 0.0 111.539 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.49 -166.37 12.23 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -163.97 69.27 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.41 -32.9 70.6 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 116.71 -1.614 . . . . 0.0 109.539 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.0 74.03 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.55 1.156 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 5' ' ' ARG . 1.5 mp0 -84.73 26.66 0.8 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.0 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.437 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -157.21 25.18 0.3 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 112.662 -2.063 . . . . 0.0 106.028 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.81 -50.35 0.83 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.713 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.15 60.09 3.12 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 55.23 34.52 22.89 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.482 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.16 -50.4 2.18 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.28 166.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.918 -1.141 . . . . 0.0 109.19 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -166.64 121.77 1.14 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.1 t -121.89 -58.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 124.832 1.333 . . . . 0.0 109.04 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.413 ' HD1' ' HD1' ' A' ' 14' ' ' HIS . 59.9 t-80 75.13 -49.84 0.65 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 126.187 2.179 . . . . 0.0 110.955 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 16' ' ' PHE . 4.9 m80 -164.99 165.61 20.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -76.12 18.48 0.28 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 14' ' ' HIS . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.5 -161.77 30.23 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m 59.13 14.52 3.55 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.18 -29.87 65.97 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.105 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 pttm . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.258 -1.83 . . . . 0.0 111.471 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.24 69.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.623 0.725 . . . . 0.0 109.079 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -82.64 31.48 0.41 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.195 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 47.23 38.67 7.32 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.825 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.461 HH11 ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -153.13 22.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.512 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.513 ' CD2' ' H ' ' A' ' 7' ' ' ASP . 5.8 p80 -178.32 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.901 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 7.3 m-20 49.78 63.85 2.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.721 1.263 . . . . 0.0 109.953 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.433 ' H ' ' CE1' ' A' ' 6' ' ' HIS . 34.9 t -58.55 -55.75 30.97 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.109 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 47.09 49.3 18.61 Favored Glycine 0 N--CA 1.497 2.746 0 O-C-N 124.979 1.425 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.6 p90 48.06 -173.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 125.474 1.338 . . . . 0.0 113.433 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -158.41 83.43 0.84 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.931 1.348 . . . . 0.0 111.06 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.37 -23.65 24.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.751 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 63.28 16.26 9.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.039 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.23 150.65 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 49.47 24.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.585 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -84.5 0.21 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -150.97 7.68 0.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.418 0.716 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.09 -33.58 69.24 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 123.604 0.565 . . . . 0.0 109.76 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 pttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.914 -1.517 . . . . 0.0 110.716 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 122.235 1.017 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.782 0.801 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 17' ' ' LEU . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 122.095 0.95 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.422 0.63 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.625 0.726 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 20' ' ' PHE . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 122.322 1.058 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.45 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 25' ' ' GLY . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 21' ' ' ALA . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 24' ' ' VAL . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 20' ' ' PHE . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 20' ' ' PHE . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.487 0.66 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 20' ' ' PHE . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.07 60.7 2.03 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.35 1.031 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.31 35.88 0.4 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.365 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -154.98 13.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.887 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -68.31 71.95 0.19 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.774 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.47 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.68 45.6 12.78 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.024 0.916 . . . . 0.0 110.129 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -68.77 -34.98 76.47 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.027 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.66 4.49 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.18 163.58 9.05 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.415 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.26 104.69 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 18' ' ' VAL . 65.6 t -81.99 -44.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.88 30.86 14.62 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -156.63 110.55 2.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.107 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -83.6 51.63 2.06 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.498 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG23 HG11 ' A' ' 12' ' ' VAL . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' CG ' ' A' ' 28' ' ' LYS . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.82 150.92 17.03 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.3 m -88.06 32.77 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.301 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -58.61 -36.13 73.56 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 22' ' ' GLU . 1.2 ptmt . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.061 -1.923 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 5' ' ' ARG . . . -168.59 142.84 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.009 0.818 . . . . 0.0 110.07 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.51 32.6 1.98 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.638 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 2' ' ' ALA . 3.2 p90 -152.02 62.91 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 2' ' ' ALA . 4.4 ppt_? -164.08 33.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.561 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.9 t60 51.16 17.43 0.47 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.588 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 52.72 32.06 11.44 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.331 0.586 . . . . 0.0 111.684 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.2 m 55.82 17.06 2.3 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.693 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.31 88.71 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.62 -175.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.279 0.635 . . . . 0.0 111.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -174.0 113.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.26 -34.2 53.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.272 -1.785 . . . . 0.0 108.134 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 67.86 -18.56 0.15 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.882 -1.508 . . . . 0.0 114.452 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.78 93.54 2.22 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 10.87 3.0 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.11 79.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -45.26 -34.41 2.86 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.365 0.686 . . . . 0.0 112.761 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -137.82 -26.42 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.034 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 116.905 -1.522 . . . . 0.0 109.097 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.97 146.64 25.13 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.325 1.059 . . . . 0.0 112.031 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.83 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.308 -2.223 . . . . 0.0 106.974 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -81.79 34.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.619 -1.628 . . . . 0.0 112.449 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -76.45 76.19 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t60 51.26 11.97 0.12 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.72 29.26 18.02 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.84 0.829 . . . . 0.0 109.57 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.3 p -70.88 -31.77 68.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.87 89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HE2' HG23 ' A' ' 12' ' ' VAL . 37.9 p90 -70.71 -165.13 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 124.045 0.497 . . . . 0.0 111.139 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -172.47 115.58 0.32 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG23 ' HE2' ' A' ' 10' ' ' TYR . 55.1 t -73.42 -54.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.523 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -178.15 -51.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.42 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -155.55 114.93 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.815 1.322 . . . . 0.0 108.971 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -123.15 15.73 9.87 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -37.36 3.53 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m 56.54 14.15 1.59 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 124.36 0.683 . . . . 0.0 112.481 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -67.26 -23.55 65.71 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.268 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 pttm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.529 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.22 105.09 17.58 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.4 120.24 10.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -80.43 54.71 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.723 1.264 . . . . 0.0 110.364 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -101.34 49.56 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.4 -1.727 . . . . 0.0 108.539 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 60.89 17.96 8.3 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.695 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.0 t0 59.4 56.21 3.85 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 m -81.3 57.17 3.12 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.256 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . -178.29 -2.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.819 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' GLY . 1.1 t80 -167.27 -179.89 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.168 0.509 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -171.33 100.17 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.51 -29.27 34.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.745 -1.571 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.1 26.78 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.753 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.2 p80 36.89 42.54 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 123.141 1.448 . . . . 0.0 112.998 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 13.45 0.14 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.683 -2.053 . . . . 0.0 115.502 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 14' ' ' HIS . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 17' ' ' LEU . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.1 -124.75 14.42 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 p -167.18 -42.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.141 0.553 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.17 -38.34 16.49 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.247 0 O-C-N 125.132 1.52 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 5' ' ' ARG . . . -141.69 133.54 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.366 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -126.52 17.75 7.54 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.128 0.893 . . . . 0.0 111.633 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' H ' ' NH1' ' A' ' 5' ' ' ARG . 2.1 p90 -107.02 62.14 0.62 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.141 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -150.52 45.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.027 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m80 53.65 59.86 4.05 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.113 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.27 71.19 5.78 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.6 p -62.36 -38.03 87.97 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.66 -101.49 0.22 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.94 160.81 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.786 0.803 . . . . 0.0 111.643 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.82 122.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.63 -52.82 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.041 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -169.26 -2.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.889 1.368 . . . . 0.0 110.899 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 13' ' ' HIS . 34.4 t60 43.04 66.27 0.81 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.159 0.912 . . . . 0.0 111.965 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 8.33 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.84 -1.527 . . . . 0.0 112.369 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 146.93 31.6 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 p -163.79 -39.7 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.9 43.79 1.14 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.609 -1.662 . . . . 0.0 110.124 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.37 70.31 0.85 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.86 80.09 2.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.12 0.962 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 61.2 m-85 -148.66 29.09 0.85 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.637 -1.62 . . . . 0.0 107.617 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 40.54 35.46 0.3 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 125.114 1.509 . . . . 0.0 111.816 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 t60 73.73 51.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 111.682 -2.508 . . . . 0.0 111.335 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t0 52.4 52.36 14.35 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.813 -1.539 . . . . 0.0 109.699 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 t 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.57 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.21 -37.88 3.1 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.88 165.24 23.0 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -170.37 104.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.75 -55.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -179.33 -59.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.256 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -170.47 -111.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.352 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 48.8 48.27 20.38 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.25 -170.12 18.44 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m 43.54 36.34 1.16 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.511 0.672 . . . . 0.0 112.759 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.43 -36.7 66.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.25 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 116.23 -1.843 . . . . 0.0 109.843 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.64 -166.46 0.77 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.865 0.84 . . . . 0.0 110.004 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.58 101.08 10.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -86.67 51.61 2.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.079 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -131.67 50.96 2.18 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.95 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 50.5 40.09 22.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.3 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.84 80.34 6.25 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 t -65.33 -29.25 69.97 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.587 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.55 -12.78 9.46 Favored Glycine 0 N--CA 1.496 2.666 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.119 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -165.4 163.59 19.76 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.869 0.842 . . . . 0.0 112.057 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -172.17 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.95 -33.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 113.28 -1.782 . . . . 0.0 108.947 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 4.79 1.18 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -167.96 143.49 3.81 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.987 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.02 26.76 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.577 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.51 -163.18 11.34 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 p -155.01 70.81 0.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -141.67 -2.49 1.21 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.466 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 115.707 -2.092 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.04 72.53 0.49 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.348 1.03 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.4 45.58 1.2 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.009 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.75 18.33 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.356 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -81.86 78.98 8.51 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.397 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.7 m80 65.96 76.07 0.32 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.0 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.81 30.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 m 63.69 8.76 3.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.938 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.63 -101.47 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -162.35 161.44 27.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.516 0.674 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -163.75 106.85 0.97 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.13 -57.02 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.163 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.24 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.108 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 46.94 57.91 5.24 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.981 1.372 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -81.91 27.24 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.277 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 20' ' ' PHE . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.52 77.92 1.03 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 m -68.23 -18.3 64.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.946 -0.627 . . . . 0.0 112.098 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.91 2.94 2.37 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 124.16 0.913 . . . . 0.0 112.206 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 129.55 8.59 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.576 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.94 20.9 1.72 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.03 0.831 . . . . 0.0 112.028 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 53.56 58.59 5.03 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -81.52 67.83 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.29 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -165.15 -64.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.398 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t0 53.48 55.49 8.57 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.585 1.178 . . . . 0.0 110.051 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -57.59 -32.42 67.16 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.782 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.21 17.19 56.71 Favored Glycine 0 N--CA 1.497 2.763 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.035 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 61.94 157.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.207 1.003 . . . . 0.0 113.177 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -176.84 127.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.04 -34.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 124.62 1.2 . . . . 0.0 110.844 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 77.95 -53.75 0.51 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.654 1.846 . . . . 0.0 110.288 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -176.86 161.57 2.01 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 123.893 0.746 . . . . 0.0 109.824 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 51.57 0.08 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.154 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 25' ' ' GLY . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 21' ' ' ALA . . . 73.51 40.95 45.98 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -53.73 -35.64 61.42 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.241 -0.979 . . . . 0.0 112.541 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.63 -23.32 11.52 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.707 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -147.26 178.49 8.36 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.878 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -95.91 96.09 8.68 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.47 -1.695 . . . . 0.0 106.555 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 4.2 m-85 -84.7 51.02 2.02 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.142 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 45.22 24.18 0.13 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.949 -1.478 . . . . 0.0 114.478 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -173.72 9.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.398 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' GLU . 13.6 t70 -80.7 21.78 0.64 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p 44.6 20.03 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.47 -65.3 3.24 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.05 165.8 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.403 0.62 . . . . 0.0 112.087 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.25 127.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' HIS . 53.6 t -97.11 -64.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.511 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 54.64 6.35 0.11 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.778 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . 30.3 m170 -78.04 -83.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 50.3 22.19 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.57 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.9 m -59.87 -33.07 71.33 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m120 58.3 6.34 0.53 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 116.315 -1.803 . . . . 0.0 109.16 179.749 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.935 0.398 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 4' ' ' PHE . . . -133.84 121.87 22.4 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.72 23.0 0.34 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.721 0.772 . . . . 0.0 112.103 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 34.9 p90 -143.21 20.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.9 ttm-85 -80.56 78.18 7.31 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.738 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 t60 59.0 27.5 16.45 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.07 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 57.99 67.23 0.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.934 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -51.35 -32.94 27.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.934 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.66 31.18 52.93 Favored Glycine 0 N--CA 1.497 2.761 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.809 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -162.83 165.3 25.5 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.45 0.643 . . . . 0.0 112.001 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -164.63 103.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -77.41 -30.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.235 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.2 m80 78.34 -51.16 0.48 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.444 1.715 . . . . 0.0 109.4 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -82.92 -153.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.825 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 53.07 31.64 11.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 24' ' ' VAL . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 20' ' ' PHE . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.64 22.15 2.55 Favored Glycine 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t 55.98 22.46 5.82 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -138.85 -32.34 0.69 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.24 0.337 . . . . 0.0 111.529 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -179.782 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.99 57.18 0.66 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.982 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.69 28.65 1.11 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.022 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 22.38 13.13 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.974 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 6.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.024 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -80.89 -54.63 5.42 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.791 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.6 23.78 0.4 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.621 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 -44.95 7.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.4 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.58 47.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.279 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 p90 39.08 -149.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.12 126.06 3.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.9 t -89.74 -30.58 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.754 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 78.51 -33.6 0.16 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.786 1.304 . . . . 0.0 111.333 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -77.29 79.31 3.81 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.904 0.859 . . . . 0.0 109.169 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.0 33.85 0.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.308 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 20' ' ' PHE . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.17 111.85 0.47 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 t -157.13 -33.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.963 0.449 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.88 41.36 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.699 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.51 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.754 0.311 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 52.84 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.513 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.38 34.76 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.368 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' C ' ' H ' ' A' ' 6' ' ' HIS . 24.9 m-85 54.53 24.32 5.26 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.305 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.67 9.83 1.3 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.911 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 4' ' ' PHE . 58.6 m-70 -81.4 -20.27 40.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.529 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.2 t70 58.89 29.71 19.21 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.223 0.952 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.2 m -48.02 -21.18 0.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.787 -1.551 . . . . 0.0 114.073 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.06 -27.32 57.12 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 123.997 0.81 . . . . 0.0 112.425 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.02 -179.77 2.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.711 0.301 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -174.43 112.74 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.3 t -80.17 -1.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.279 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 69.39 -2.29 1.93 Allowed 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.604 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.2 p80 26.08 69.71 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.621 1.201 . . . . 0.0 112.932 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -135.34 29.97 3.28 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.494 -2.139 . . . . 0.0 111.539 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 20' ' ' PHE . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.49 -166.37 12.23 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -163.97 69.27 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.41 -32.9 70.6 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 116.71 -1.614 . . . . 0.0 109.539 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.0 74.03 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.55 1.156 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 5' ' ' ARG . 1.5 mp0 -84.73 26.66 0.8 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.0 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.437 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -157.21 25.18 0.3 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 112.662 -2.063 . . . . 0.0 106.028 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.81 -50.35 0.83 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.713 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.15 60.09 3.12 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 55.23 34.52 22.89 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.482 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.16 -50.4 2.18 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.28 166.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.918 -1.141 . . . . 0.0 109.19 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -166.64 121.77 1.14 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.1 t -121.89 -58.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 124.832 1.333 . . . . 0.0 109.04 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 75.13 -49.84 0.65 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 126.187 2.179 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -164.99 165.61 20.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -76.12 18.48 0.28 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.5 -161.77 30.23 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m 59.13 14.52 3.55 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.18 -29.87 65.97 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.105 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 pttm . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.258 -1.83 . . . . 0.0 111.471 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.24 69.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.623 0.725 . . . . 0.0 109.079 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -82.64 31.48 0.41 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.195 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 47.23 38.67 7.32 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.825 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.476 HH11 ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -153.13 22.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.512 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 7' ' ' ASP . 5.8 p80 -178.32 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.901 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.519 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 7.3 m-20 49.78 63.85 2.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.721 1.263 . . . . 0.0 109.953 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.488 ' H ' ' CE1' ' A' ' 6' ' ' HIS . 34.9 t -58.55 -55.75 30.97 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.109 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 47.09 49.3 18.61 Favored Glycine 0 N--CA 1.497 2.746 0 O-C-N 124.979 1.425 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.618 ' CD1' HG23 ' A' ' 12' ' ' VAL . 13.6 p90 48.06 -173.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 125.474 1.338 . . . . 0.0 113.433 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -158.41 83.43 0.84 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.931 1.348 . . . . 0.0 111.06 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG23 ' CD1' ' A' ' 10' ' ' TYR . 59.9 t -70.37 -23.65 24.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.751 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 63.28 16.26 9.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.039 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.23 150.65 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 49.47 24.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.585 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -84.5 0.21 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -150.97 7.68 0.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.418 0.716 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.09 -33.58 69.24 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 123.604 0.565 . . . . 0.0 109.76 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 pttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.914 -1.517 . . . . 0.0 110.716 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 122.235 1.017 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.782 0.801 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 17' ' ' LEU . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 122.095 0.95 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.422 0.63 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.625 0.726 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 20' ' ' PHE . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 122.322 1.058 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.45 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 25' ' ' GLY . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 21' ' ' ALA . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 24' ' ' VAL . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 20' ' ' PHE . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 20' ' ' PHE . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.487 0.66 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 20' ' ' PHE . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.07 60.7 2.03 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 124.35 1.031 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.31 35.88 0.4 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.365 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -154.98 13.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.887 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -68.31 71.95 0.19 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.774 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.47 -21.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.011 -1.449 . . . . 0.0 109.613 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 t70 59.68 45.6 12.78 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.024 0.916 . . . . 0.0 110.129 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.5 t -68.77 -34.98 76.47 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.027 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.66 4.49 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.18 163.58 9.05 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.916 -0.642 . . . . 0.0 109.415 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -172.26 104.69 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 18' ' ' VAL . 65.6 t -81.99 -44.02 19.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.88 30.86 14.62 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.537 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -156.63 110.55 2.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.107 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -83.6 51.63 2.06 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.498 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -132.86 -50.39 0.89 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -68.91 -46.79 67.4 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG23 HG11 ' A' ' 12' ' ' VAL . 2.2 t -66.27 -38.0 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.852 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -55.57 -39.97 71.35 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.817 0.817 . . . . 0.0 109.457 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t80 -68.81 -51.69 38.09 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.666 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.98 -50.76 45.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HG2' ' CG ' ' A' ' 28' ' ' LYS . 36.7 mt-10 -60.56 -35.18 75.43 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 114.398 -1.274 . . . . 0.0 113.417 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.09 -53.75 5.85 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 20' ' ' PHE . 3.9 t -68.3 -49.37 67.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 113.585 -1.643 . . . . 0.0 111.646 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.82 150.92 17.03 Favored Glycine 0 N--CA 1.495 2.585 0 O-C-N 124.311 1.007 . . . . 0.0 111.471 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.3 m -88.06 32.77 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.301 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -58.61 -36.13 73.56 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' CG ' ' HG2' ' A' ' 22' ' ' GLU . 1.2 ptmt . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 116.061 -1.923 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 5' ' ' ARG . . . -168.59 142.84 3.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 124.009 0.818 . . . . 0.0 110.07 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.51 32.6 1.98 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.638 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 2' ' ' ALA . 3.2 p90 -152.02 62.91 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.469 ' HG2' ' HB3' ' A' ' 2' ' ' ALA . 4.4 ppt_? -164.08 33.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.561 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.9 t60 51.16 17.43 0.47 Allowed 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.588 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 52.72 32.06 11.44 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.331 0.586 . . . . 0.0 111.684 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.2 m 55.82 17.06 2.3 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.693 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.31 88.71 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.62 -175.12 0.24 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 124.279 0.635 . . . . 0.0 111.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -174.0 113.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.26 -34.2 53.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.272 -1.785 . . . . 0.0 108.134 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 67.86 -18.56 0.15 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.882 -1.508 . . . . 0.0 114.452 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.78 93.54 2.22 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 10.87 3.0 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -63.54 -22.42 66.88 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.384 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -66.86 -44.98 79.58 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.3 t -69.28 -47.0 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.638 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.02 -29.65 13.12 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.847 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.839 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t80 -84.29 -50.76 7.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.837 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.33 -48.13 18.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.96 -37.27 71.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.541 1.151 . . . . 0.0 111.922 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -46.5 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.12 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 20' ' ' PHE . 6.7 t -55.21 -52.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.11 79.03 0.05 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -45.26 -34.41 2.86 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.365 0.686 . . . . 0.0 112.761 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -137.82 -26.42 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.034 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 116.905 -1.522 . . . . 0.0 109.097 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.97 146.64 25.13 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.325 1.059 . . . . 0.0 112.031 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.83 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.308 -2.223 . . . . 0.0 106.974 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -81.79 34.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.619 -1.628 . . . . 0.0 112.449 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -76.45 76.19 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t60 51.26 11.97 0.12 Allowed 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 t70 61.72 29.26 18.02 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.84 0.829 . . . . 0.0 109.57 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.3 p -70.88 -31.77 68.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.87 89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' HE2' HG23 ' A' ' 12' ' ' VAL . 37.9 p90 -70.71 -165.13 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 124.045 0.497 . . . . 0.0 111.139 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -172.47 115.58 0.32 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG23 ' HE2' ' A' ' 10' ' ' TYR . 55.1 t -73.42 -54.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.64 -1.618 . . . . 0.0 108.523 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -178.15 -51.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 113.334 -1.757 . . . . 0.0 107.42 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -155.55 114.93 3.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.815 1.322 . . . . 0.0 108.971 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -123.15 15.73 9.87 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.065 0.936 . . . . 0.0 110.465 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -68.95 -21.68 64.18 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.2 mp -65.3 -44.9 86.44 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 t -68.66 -46.5 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 113.334 -1.757 . . . . 0.0 108.377 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -53.85 -31.09 48.29 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.566 1.166 . . . . 0.0 109.562 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -77.53 -50.15 13.22 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.98 -7.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -93.92 -3.21 52.06 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -142.03 -34.76 0.45 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.475 0.655 . . . . 0.0 110.347 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.07 -38.8 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.76 -37.36 3.53 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-N 113.469 -1.696 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 m 56.54 14.15 1.59 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 124.36 0.683 . . . . 0.0 112.481 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.26 -23.55 65.71 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.268 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 pttm . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.529 179.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.22 105.09 17.58 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.4 120.24 10.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -80.43 54.71 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.723 1.264 . . . . 0.0 110.364 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -101.34 49.56 0.87 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.4 -1.727 . . . . 0.0 108.539 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 60.89 17.96 8.3 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.695 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.0 t0 59.4 56.21 3.85 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.5 m -81.3 57.17 3.12 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.256 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . -178.29 -2.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.466 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.819 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' H ' ' H ' ' A' ' 9' ' ' GLY . 1.1 t80 -167.27 -179.89 4.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.168 0.509 . . . . 0.0 110.142 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -171.33 100.17 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.51 -29.27 34.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.745 -1.571 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.1 26.78 0.16 Allowed 'General case' 0 N--CA 1.503 2.213 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.753 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.2 p80 36.89 42.54 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 123.141 1.448 . . . . 0.0 112.998 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 13.45 0.14 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 112.683 -2.053 . . . . 0.0 115.502 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 14' ' ' HIS . 1.3 m-85 -57.57 -35.35 70.26 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 121.854 0.835 . . . . 0.0 111.352 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 17' ' ' LEU . 4.3 mp -66.56 -38.11 86.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.903 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.43 -44.2 77.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.721 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -51.1 -34.56 31.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.754 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -75.94 -51.18 12.99 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.494 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -42.48 -48.38 5.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.097 0.873 . . . . 0.0 113.225 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.13 -20.44 1.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 125.435 1.709 . . . . 0.0 114.427 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -145.07 32.67 1.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.967 0.792 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.3 -32.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.268 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.1 -124.75 14.42 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 p -167.18 -42.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.141 0.553 . . . . 0.0 109.818 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.17 -38.34 16.49 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.247 0 O-C-N 125.132 1.52 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.1 t70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.272 0.558 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB1' ' NH1' ' A' ' 5' ' ' ARG . . . -141.69 133.54 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.366 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -126.52 17.75 7.54 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.128 0.893 . . . . 0.0 111.633 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' H ' ' NH1' ' A' ' 5' ' ' ARG . 2.1 p90 -107.02 62.14 0.62 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.141 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' NH1' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -150.52 45.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.142 -1.845 . . . . 0.0 109.027 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 m80 53.65 59.86 4.05 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 113.35 -1.75 . . . . 0.0 112.113 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.27 71.19 5.78 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.6 p -62.36 -38.03 87.97 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.66 -101.49 0.22 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -167.94 160.81 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.786 0.803 . . . . 0.0 111.643 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.82 122.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.63 -52.82 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.041 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -169.26 -2.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.889 1.368 . . . . 0.0 110.899 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 13' ' ' HIS . 34.4 t60 43.04 66.27 0.81 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.159 0.912 . . . . 0.0 111.965 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 8.33 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 113.84 -1.527 . . . . 0.0 112.369 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.14 28.18 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.386 -1.734 . . . . 0.0 107.861 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.2 mt -63.25 -33.2 74.98 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.688 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.73 -37.61 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.01 -45.4 85.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.61 -12.74 48.65 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.8 -42.88 7.38 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -31.37 61.73 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.125 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -83.11 -57.72 3.16 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.794 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.4 t -66.54 -59.94 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.094 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.82 146.93 31.6 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.364 -1.895 . . . . 0.0 108.364 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.6 p -163.79 -39.7 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.9 43.79 1.14 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 116.609 -1.662 . . . . 0.0 110.124 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.37 70.31 0.85 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.86 80.09 2.12 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.12 0.962 . . . . 0.0 109.893 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 61.2 m-85 -148.66 29.09 0.85 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.637 -1.62 . . . . 0.0 107.617 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 40.54 35.46 0.3 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 125.114 1.509 . . . . 0.0 111.816 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 t60 73.73 51.84 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 111.682 -2.508 . . . . 0.0 111.335 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.0 t0 52.4 52.36 14.35 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 113.813 -1.539 . . . . 0.0 109.699 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 t 62.12 30.03 17.7 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 113.397 -1.729 . . . . 0.0 109.57 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.21 -37.88 3.1 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.88 165.24 23.0 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -170.37 104.84 0.28 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.0 t -57.75 -55.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 112.587 -2.097 . . . . 0.0 110.413 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -179.33 -59.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.256 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -170.47 -111.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.352 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 48.8 48.27 20.38 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 124.208 1.956 . . . . 0.0 109.78 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' VAL . 7.0 t80 -141.83 117.16 10.15 Favored 'General case' 0 C--N 1.298 -1.632 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mt 86.0 -27.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' PHE . 89.1 t -102.07 -29.16 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.715 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.78 -46.77 86.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -65.6 -12.9 57.25 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.995 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.7 36.8 4.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.01 0.909 . . . . 0.0 109.824 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -141.83 -43.34 0.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.493 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 -39.6 12.74 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -76.26 -54.77 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.42 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.25 -170.12 18.44 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.1 m 43.54 36.34 1.16 Allowed 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.511 0.672 . . . . 0.0 112.759 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.43 -36.7 66.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.25 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 116.23 -1.843 . . . . 0.0 109.843 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.64 -166.46 0.77 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.865 0.84 . . . . 0.0 110.004 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.58 101.08 10.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -86.67 51.61 2.28 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.079 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttm-85 -131.67 50.96 2.18 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.95 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 50.5 40.09 22.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.3 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.84 80.34 6.25 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 t -65.33 -29.25 69.97 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.587 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.55 -12.78 9.46 Favored Glycine 0 N--CA 1.496 2.666 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.119 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -165.4 163.59 19.76 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.869 0.842 . . . . 0.0 112.057 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -172.17 103.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.95 -33.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 113.28 -1.782 . . . . 0.0 108.947 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 4.79 1.18 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -167.96 143.49 3.81 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.987 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.02 26.76 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.577 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -65.94 -45.23 82.57 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.38 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.4 mp -60.43 -37.92 82.44 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.858 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.13 -37.64 67.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -61.19 -47.0 88.16 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -58.59 -47.6 83.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.58 13.02 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.166 -1.379 . . . . 0.0 114.042 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' PHE . 33.1 mm-40 -129.7 1.07 4.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 124.087 0.867 . . . . 0.0 112.502 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.7 -37.24 1.19 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 4.3 t -84.41 -45.44 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.51 -163.18 11.34 Favored Glycine 0 N--CA 1.492 2.43 0 CA-C-N 112.72 -2.036 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 p -155.01 70.81 0.77 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.67 -2.49 1.21 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.466 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 115.707 -2.092 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.04 72.53 0.49 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 124.348 1.03 . . . . 0.0 110.872 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.4 45.58 1.2 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.009 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.75 18.33 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.356 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -81.86 78.98 8.51 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.397 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.7 m80 65.96 76.07 0.32 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.0 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.81 30.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.188 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 m 63.69 8.76 3.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.938 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.63 -101.47 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -162.35 161.44 27.46 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.516 0.674 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -163.75 106.85 0.97 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.13 -57.02 4.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.163 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.24 -22.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.889 -1.96 . . . . 0.0 109.108 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 46.94 57.91 5.24 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.981 1.372 . . . . 0.0 111.145 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -81.91 27.24 0.47 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.277 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -56.07 -37.8 69.8 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.917 0.865 . . . . 0.0 110.663 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -60.75 -41.4 95.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.03 -42.8 85.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.472 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.0 -41.01 33.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 124.08 0.862 . . . . 0.0 108.714 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -75.77 -48.44 21.71 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.895 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.09 -46.46 8.61 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -52.71 -14.85 0.59 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 125.255 1.597 . . . . 0.0 114.392 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -148.79 30.71 0.8 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 123.63 0.581 . . . . 0.0 109.912 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 20' ' ' PHE . 32.9 t -132.27 -31.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.52 77.92 1.03 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 m -68.23 -18.3 64.53 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 114.946 -0.627 . . . . 0.0 112.098 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.91 2.94 2.37 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 124.16 0.913 . . . . 0.0 112.206 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.69 129.55 8.59 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.576 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.94 20.9 1.72 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.03 0.831 . . . . 0.0 112.028 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 53.56 58.59 5.03 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -81.52 67.83 7.63 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.29 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -165.15 -64.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 113.918 -1.492 . . . . 0.0 107.398 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t0 53.48 55.49 8.57 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 124.585 1.178 . . . . 0.0 110.051 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.9 p -57.59 -32.42 67.16 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.782 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.21 17.19 56.71 Favored Glycine 0 N--CA 1.497 2.763 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.035 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 61.94 157.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.207 1.003 . . . . 0.0 113.177 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -176.84 127.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.04 -34.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 124.62 1.2 . . . . 0.0 110.844 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 77.95 -53.75 0.51 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 125.654 1.846 . . . . 0.0 110.288 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -176.86 161.57 2.01 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 123.893 0.746 . . . . 0.0 109.824 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.48 51.57 0.08 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.154 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -133.35 -55.04 0.91 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.45 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.2 mp -70.03 -39.46 75.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -76.47 -41.3 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.477 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.86 -21.22 64.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.475 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -91.72 -3.19 56.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.218 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' H ' ' A' ' 25' ' ' GLY . . . -129.72 -31.83 1.95 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.0 -38.43 64.1 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.33 -59.11 2.33 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.854 -1.975 . . . . 0.0 111.456 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.76 -55.28 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.574 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 21' ' ' ALA . . . 73.51 40.95 45.98 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 105.832 -2.907 . . . . 0.0 105.832 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -53.73 -35.64 61.42 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.241 -0.979 . . . . 0.0 112.541 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -109.63 -23.32 11.52 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 116.734 -1.603 . . . . 0.0 110.707 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.563 0.697 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . . . -147.26 178.49 8.36 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.878 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -95.91 96.09 8.68 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.47 -1.695 . . . . 0.0 106.555 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 4.2 m-85 -84.7 51.02 2.02 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.142 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 45.22 24.18 0.13 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.949 -1.478 . . . . 0.0 114.478 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -173.72 9.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.398 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' GLU . 13.6 t70 -80.7 21.78 0.64 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p 44.6 20.03 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.47 -65.3 3.24 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -161.05 165.8 29.17 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.403 0.62 . . . . 0.0 112.087 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.25 127.04 0.26 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 14' ' ' HIS . 53.6 t -97.11 -64.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.511 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 54.64 6.35 0.11 Allowed 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.778 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.556 ' H ' HG12 ' A' ' 12' ' ' VAL . 30.3 m170 -78.04 -83.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 50.3 22.19 0.94 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.998 0.904 . . . . 0.0 113.07 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -66.39 -34.7 78.56 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.146 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.6 mp -61.48 -37.7 84.6 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.101 -1.409 . . . . 0.0 107.985 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.38 -44.66 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -64.88 -9.45 21.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 124.436 1.085 . . . . 0.0 109.264 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -115.36 -2.86 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.28 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.08 -34.92 5.22 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.385 0.612 . . . . 0.0 111.069 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.25 12.65 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.843 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.79 -24.05 1.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.199 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.44 -51.4 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 124.069 0.856 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.57 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.495 2.591 0 O-C-N 124.323 1.014 . . . . 0.0 114.216 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.9 m -59.87 -33.07 71.33 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 58.3 6.34 0.53 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 116.315 -1.803 . . . . 0.0 109.16 179.749 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.935 0.398 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 4' ' ' PHE . . . -133.84 121.87 22.4 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.72 23.0 0.34 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.721 0.772 . . . . 0.0 112.103 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 34.9 p90 -143.21 20.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.9 ttm-85 -80.56 78.18 7.31 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.738 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 t60 59.0 27.5 16.45 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.07 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 57.99 67.23 0.98 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.449 -1.25 . . . . 0.0 108.934 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -51.35 -32.94 27.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.934 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 54.66 31.18 52.93 Favored Glycine 0 N--CA 1.497 2.761 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.809 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -162.83 165.3 25.5 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.45 0.643 . . . . 0.0 112.001 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -164.63 103.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.0 t -77.41 -30.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.235 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.2 m80 78.34 -51.16 0.48 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.444 1.715 . . . . 0.0 109.4 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -82.92 -153.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.825 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 53.07 31.64 11.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 123.719 1.723 . . . . 0.0 110.295 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 18' ' ' VAL . 1.9 t80 -149.4 110.93 4.48 Favored 'General case' 0 C--N 1.299 -1.621 1 N-CA-C 96.466 -5.383 . . . . 0.0 96.466 179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 16' ' ' PHE . 1.1 tp 86.62 -27.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 16' ' ' PHE . 47.0 t -93.26 -39.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -55.28 -27.81 49.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.454 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 24' ' ' VAL . 20.9 t80 -87.22 -42.52 12.89 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.305 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.95 -46.81 43.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 123.838 0.711 . . . . 0.0 112.762 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -40.46 27.24 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 124.906 1.379 . . . . 0.0 111.455 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.5 -48.79 13.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.081 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 20' ' ' PHE . 30.5 t -48.82 -52.11 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.505 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 48.64 22.15 2.55 Favored Glycine 0 N--CA 1.501 3.011 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.551 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t 55.98 22.46 5.82 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -138.85 -32.34 0.69 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.24 0.337 . . . . 0.0 111.529 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -179.782 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.99 57.18 0.66 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.982 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -88.69 28.65 1.11 Allowed 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.022 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 22.38 13.13 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.974 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 6.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.024 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -80.89 -54.63 5.42 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.539 -1.664 . . . . 0.0 108.791 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.6 23.78 0.4 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 113.765 -1.562 . . . . 0.0 107.621 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 -44.95 7.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.4 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.58 47.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.279 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 p90 39.08 -149.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.12 126.06 3.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.9 t -89.74 -30.58 5.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.754 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 78.51 -33.6 0.16 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.786 1.304 . . . . 0.0 111.333 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -77.29 79.31 3.81 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.904 0.859 . . . . 0.0 109.169 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -77.0 33.85 0.15 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.308 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -122.43 -48.89 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 103.917 -2.623 . . . . 0.0 103.917 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mp -72.63 -45.55 58.45 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.8 -36.34 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.843 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.18 -37.59 80.67 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -63.57 -51.01 67.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.27 -51.22 19.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.386 1.054 . . . . 0.0 111.471 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -62.96 -37.0 85.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 124.652 1.22 . . . . 0.0 110.688 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.26 12.73 25.77 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 113.246 -1.797 . . . . 0.0 114.472 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 20' ' ' PHE . 99.2 t -131.79 -44.2 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.226 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.17 111.85 0.47 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.2 t -157.13 -33.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.963 0.449 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.88 41.36 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.699 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.291 -1.814 . . . . 0.0 110.51 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.754 0.311 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.35 52.84 0.32 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.513 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.38 34.76 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.368 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' C ' ' H ' ' A' ' 6' ' ' HIS . 24.9 m-85 54.53 24.32 5.26 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.374 -1.285 . . . . 0.0 113.305 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.67 9.83 1.3 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.911 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 4' ' ' PHE . 58.6 m-70 -81.4 -20.27 40.82 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.529 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.2 t70 58.89 29.71 19.21 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.223 0.952 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.2 m -48.02 -21.18 0.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.787 -1.551 . . . . 0.0 114.073 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.06 -27.32 57.12 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 123.997 0.81 . . . . 0.0 112.425 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.02 -179.77 2.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.711 0.301 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -174.43 112.74 0.16 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.3 t -80.17 -1.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.279 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 69.39 -2.29 1.93 Allowed 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.604 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.2 p80 26.08 69.71 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 124.621 1.201 . . . . 0.0 112.932 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -135.34 29.97 3.28 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 112.494 -2.139 . . . . 0.0 111.539 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -120.08 -49.14 2.31 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.3 mp -64.41 -39.15 93.29 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.32 -45.99 58.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.053 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -51.63 -33.02 31.44 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.991 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' VAL . 3.1 m-85 -76.67 -51.2 11.96 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.588 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -43.31 -46.53 6.4 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -51.64 -19.6 1.63 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 125.164 1.54 . . . . 0.0 114.547 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -145.48 27.8 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 123.972 0.795 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 20' ' ' PHE . 54.5 t -133.64 -28.03 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.188 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.49 -166.37 12.23 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -163.97 69.27 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -59.41 -32.9 70.6 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 116.71 -1.614 . . . . 0.0 109.539 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.0 74.03 0.26 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.55 1.156 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 5' ' ' ARG . 1.5 mp0 -84.73 26.66 0.8 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.0 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -83.99 26.82 0.7 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.437 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -157.21 25.18 0.3 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 112.662 -2.063 . . . . 0.0 106.028 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.81 -50.35 0.83 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.713 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.15 60.09 3.12 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 55.23 34.52 22.89 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.482 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.16 -50.4 2.18 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.299 -2.72 . . . . 0.0 106.299 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.28 166.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.918 -1.141 . . . . 0.0 109.19 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -166.64 121.77 1.14 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.1 t -121.89 -58.01 2.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 124.832 1.333 . . . . 0.0 109.04 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 75.13 -49.84 0.65 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 126.187 2.179 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -164.99 165.61 20.0 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -76.12 18.48 0.28 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -66.29 -24.91 66.64 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.605 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -43.37 90.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 20' ' ' PHE . 1.0 OUTLIER -67.13 -47.02 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.217 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.19 2.72 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.87 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 18' ' ' VAL . 13.0 t80 -139.38 11.73 2.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.328 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.32 -33.42 0.27 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.29 0.567 . . . . 0.0 111.496 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -72.45 -43.32 63.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -82.4 -44.42 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.861 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.1 -59.07 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.5 -161.77 30.23 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.3 m 59.13 14.52 3.55 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -58.18 -29.87 65.97 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.105 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 pttm . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.258 -1.83 . . . . 0.0 111.471 179.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.24 69.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.623 0.725 . . . . 0.0 109.079 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -82.64 31.48 0.41 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.195 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 47.23 38.67 7.32 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.825 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.476 HH11 ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -153.13 22.25 0.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.189 -1.368 . . . . 0.0 110.512 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 7' ' ' ASP . 5.8 p80 -178.32 -47.4 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.901 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.519 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 7.3 m-20 49.78 63.85 2.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.721 1.263 . . . . 0.0 109.953 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.488 ' H ' ' CE1' ' A' ' 6' ' ' HIS . 34.9 t -58.55 -55.75 30.97 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.109 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 47.09 49.3 18.61 Favored Glycine 0 N--CA 1.497 2.746 0 O-C-N 124.979 1.425 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.618 ' CD1' HG23 ' A' ' 12' ' ' VAL . 13.6 p90 48.06 -173.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 125.474 1.338 . . . . 0.0 113.433 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -158.41 83.43 0.84 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.931 1.348 . . . . 0.0 111.06 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG23 ' CD1' ' A' ' 10' ' ' TYR . 59.9 t -70.37 -23.65 24.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 112.758 -2.019 . . . . 0.0 109.751 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 63.28 16.26 9.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.039 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.23 150.65 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 49.47 24.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.585 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -26.42 67.52 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.43 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -71.55 -34.38 69.95 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.84 -45.07 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.073 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.15 -21.67 66.35 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.595 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -94.4 -19.83 20.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.246 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.16 -69.3 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 123.801 0.688 . . . . 0.0 110.802 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -50.66 -36.7 36.89 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.041 0.838 . . . . 0.0 112.18 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.73 16.44 19.06 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.65 -33.17 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -84.5 0.21 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -150.97 7.68 0.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 124.418 0.716 . . . . 0.0 110.94 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.09 -33.58 69.24 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 123.604 0.565 . . . . 0.0 109.76 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 pttp . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 116.914 -1.517 . . . . 0.0 110.716 179.824 . . . . . . . . 0 0 . 1 stop_ save_